v3 Template
B

BOOST Pharma ApS

Biotechnology / Healthcare ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$34.0M
Funding Rounds
1
Last Funding
2025-11-03

About BOOST Pharma ApS

BOOST Pharma is a biotechnology company focused on developing a novel cell therapy treatment for Osteogenesis Imperfecta (OI), a rare genetic bone disease also known as Brittle Bone Disease. Founded on research from Karolinska Institutet in Sweden, the company aims to treat the untreatable by enhancing the quality of life for patients through innovative therapies like BT-101, using Mesenchymal Stem Cells (MSC).

Products & Services

BT-101:A first-in-class cell therapy for Osteogenesis Imperfecta (OI) using Mesenchymal Stem Cells (MSC) with high bone-forming capabilities. It is administered prenatally or postnatally to reduce fracture rates and improve bone strength, showing promising results in clinical trials with significant fracture reduction and safety.

Specialties

Cell Therapy Mesenchymal Stem Cells (MSC) Osteogenesis Imperfecta (OI) Treatment Rare Disease Therapy

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Equity
T: -
FT: Equity 		A: 34000000
MR: -
FA: 34 million
FAN: 34000000 		D: 2025-11-03
FD: 2025-11-03 		1 investors
Equity Latest
2025-11-03
$34.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Cecilia Götherström

Associate Professor for Stem Cell Science

LinkedIn (Pro only)
M

Magnus Westgren

Senior Professor

LinkedIn (Pro only)
L

Lilian Walther Jallow

Co-founder & CDO

LinkedIn (Pro only)
T

Tony Hall

Chief Medical Officer

F

Fredrik Lehmann

CMC Advisor

I

Ingelise Saunders

Chairman & CEO

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

BOOST Pharma ApS Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~260 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro